Table III.
All subjects (128 hips) | Males (64 hips) | Females (64 hips) | P-value* | |
---|---|---|---|---|
Definite AD and FAI-related deformities | 7.8% (10/128) | 7.8% (5/64) | 7.8% (5/64) | 1 |
[4.3%–13.8%] | [3.4%–17.0%] | [3.4%–17.0%] | ||
Definite AD + cam deformity | 6.3% (8/128) | 4.7% (3/64) | 7.8% (5/64) | 0.465 |
[3.2%–11.8%] | [1.6%–12.9%] | [3.4%–17.0%] | ||
Definite AD + pincer deformity | 0% (0/128) | 0% (0/64) | 0% (0/64) | – |
[0%–2.9%] | [0%–5.7%] | [0%–5.7%] | ||
Definite AD + combined deformity | 1.6% (2/128) | 3.1% (2/64) | 0% (0/64) | 0.154 |
[0.4%–5.5%] | [0.9%–10.7%] | [0%–5.7%] | ||
Borderline AD and FAI-related deformities | 15.6% (20/128) [10.3%–22.9%] | 20.3% (13/64) [12.3%–31.7%] | 10.9% (7/64) [5.4%–20.9%] | 0.144 |
Borderline AD + cam deformity | 13.3% (17/128) [8.5%–20.2%] | 17.2% (11/64) [9.9%–28.2%] | 9.4% (6/64) [4.4%–19.0%] | 0.193 |
Borderline AD + pincer deformity | 1.6% (2/128) | 1.6% (1/64) | 1.6% (1/64) | 1 |
[0.4%–5.5%] | [0.3%–8.3%] | [0.3%–8.3%] | ||
Borderline AD + combined deformity | 0.8% (1/128) | 1.6% (1/64) | 0% (0/64) | 0.315 |
[0.1%–4.3%] | [0.3%–8.3%] | [0%–5.7%] | ||
AD in total (definite and borderline) and FAI-related deformities | 23.4% (30/128) | 28.1% (18/64) | 18.7% (12/64) | 0.210 |
[16.9%–31.5%] | [18.6%–40.1%] | [11.1%–30.0%] | ||
AD in total (definite and borderline) + cam deformity | 19.5% (25/128) | 21.9% (14/64) | 17.2% (11/64) | 0.504 |
[13.6%–27.2%] | [13.5%–33.4%] | [9.9%–28.2%] | ||
AD in total (definite and borderline) + pincer deformity | 1.6% (2/128) | 1.6% (1/64) | 1.6% (1/64) | 1 |
[0.4%–5.5%] | [0.3%–8.3%] | [0.3%–8.3%] | ||
AD in total (definite and borderline) + combined deformity | 2.3% (3/128) | 4.7% (3/64) | 0% (0/64) | 0.079 |
[0.8%–6.7%] | [1.6%–12.9%] | [0%–5.7%] |
Data are shown as percentage [95% CI]. AD, acetabular dysplasia; FAI, femoroacetabular impingement.
Male versus female, evaluated with χ2 test. P-values of <0.05 were considered statistically significant.